Epigenetic control of a VDR-governed feed-forward loop that regulates p21 (waf1/cip1) expression and function in non-malignant prostate cells

Nucleic Acids Research

Volumn 39, Issue 6, 2011, Pages 2045-2056

  Thorne, James L ^a,e   Maguire, Orla ^b   Doig, Craig L ^b   Battaglia, Sebastiano ^b   Fehr, Leah ^b,c   Sucheston, Lara E ^b,c   Heinaniemi, Merja ^d   O'Neill, Laura P ^a   McCabe, Christopher J ^a   Turner, Bryan M ^a   Carlberg, Carsten ^a   Campbell, Moray J ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^e UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; VITAMIN D RECEPTOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL CYCLE ARREST; CELL SELECTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION REGULATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE EPITHELIUM; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; CALCITRIOL; CELL CYCLE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EPIGENESIS, GENETIC; FEEDBACK, PHYSIOLOGICAL; HISTONES; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; PROMOTER REGIONS, GENETIC; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL;

EID: 79953684295     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq875     Document Type: Article

References (75)

1. Colston,K., Colston,M.J. and Feldman,D. (1981) 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology, 108, 1083-1086.
2. Miyaura,C., Abe,E., Kuribayashi,T., Tanaka,H., Konno,K., Nishii,Y. and Suda,T. (1981) 1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun., 102, 937-943.
3. Abe,E., Miyaura,C., Sakagami,H., Takeda,M., Konno,K., Yamazaki,T., Yoshiki,S. and Suda,T. (1981) Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc. Natl Acad. Sci. USA, 78, 4990-4994.
4. Campbell,M.J., Elstner,E., Holden,S., Uskokovic,M. and Koeffler,H.P. (1997) Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J. Mol. Endocrinol., 19, 15-27. (Pubitemid 27345239)
5. Elstner,E., Campbell,M.J., Munker,R., Shintaku,P., Binderup,L., Heber,D., Said,J. and Koeffler,H.P. (1999) Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. Prostate, 40, 141-149. (Pubitemid 29334861)
6. Peehl,D.M., Skowronski,R.J., Leung,G.K., Wong,S.T., Stamey,T.A. and Feldman,D. (1994) Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res., 54, 805-810. (Pubitemid 24068341)
7. Colston,K., Colston,M.J., Fieldsteel,A.H. and Feldman,D. (1982) 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines. Cancer Res., 42, 856-859.
8. Blutt,S.E., Polek,T.C., Stewart,L.V., Kattan,M.W. and Weigel,N.L. (2000) A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice. Cancer Res., 60, 779-782. (Pubitemid 30129500)
9. Banach-Petrosky,W., Ouyang,X., Gao,H., Nader,K., Ji,Y., Suh,N., DiPaola,R.S. and Abate-Shen,C. (2006) Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice. Clin. Cancer Res., 12, 5895-5901.
10. Campbell,M.J., Gombart,A.F., Kwok,S.H., Park,S. and Koeffler,H.P. (2000) The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Oncogene, 19, 5091-5097.
11. Rashid,S.F., Moore,J.S., Walker,E., Driver,P.M., Engel,J., Edwards,C.E., Brown,G., Uskokovic,M.R. and Campbell,M.J. (2001) Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene, 20, 1860-1872. (Pubitemid 32458696)
12. Garland,C.F. and Garland,F.C. (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol., 9, 227-231.
13. Garland,F.C., Garland,C.F., Gorham,E.D. and Young,J.F. (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev. Med., 19, 614-622.
14. Luscombe,C.J., French,M.E., Liu,S., Saxby,M.F., Jones,P.W., Fryer,A.A. and Strange,R.C. (2001) Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes. Br. J. Cancer, 85, 1504-1509.
15. Giovannucci,E. (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control, 16, 83-95.
16. Schwartz,G.G. and Hulka,B.S. (1990) Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res., 10, 1307-1311.
17. John,E.M., Schwartz,G.G., Koo,J., Van Den,B.D. and Ingles,S.A. (2005) Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res., 65, 5470-5479.
18. Chen,T.C., Wang,L., Whitlatch,L.W., Flanagan,J.N. and Holick,M.F. (2003) Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. J. Cell Biochem., 88, 315-322. (Pubitemid 36119904)
19. Hsu,J.Y., Feldman,D., McNeal,J.E. and Peehl,D.M. (2001) Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res., 61, 2852-2856. (Pubitemid 32691924)
20. Ahonen,M.H., Tenkanen,L., Teppo,L., Hakama,M. and Tuohimaa,P. (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control, 11, 847-852.
21. Rosenfeld,M.G., Lunyak,V.V. and Glass,C.K. (2006) Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev., 20, 1405-1428. (Pubitemid 43830648)
22. Metivier,R., Penot,G., Hubner,M.R., Reid,G., Brand,H., Kos,M. and Gannon,F. (2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell, 115, 751-763. (Pubitemid 38030303)
23. Vaisanen,S., Dunlop,T.W., Sinkkonen,L., Frank,C. and Carlberg,C. (2005) Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-dihydroxyvitamin D(3). J. Mol. Biol., 350, 65-77.
24. Kang,Z., Janne,O.A. and Palvimo,J.J. (2004) Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol. Endocrinol., 18, 2633-2648.
25. Khanim,F.L., Gommersall,L.M., Wood,V.H., Smith,K.L., Montalvo,L., O'Neill,L.P., Xu,Y., Peehl,D.M., Stewart,P.M., Turner,B.M. et al. (2004) Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene, 23, 6712-6725. (Pubitemid 39280003)
26. Kim,J.Y., Son,Y.L. and Lee,Y.C. (2008) Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor. Mol. Endocrinol, 23, 251-264.
27. Ting,H.J., Bao,B.Y., Reeder,J.E., Messing,E.M. and Lee,Y.F. (2007) Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness. Mol. Cancer Res., 5, 967-980.
28. Yoon,H.G., Chan,D.W., Reynolds,A.B., Qin,J. and Wong,J. (2003) N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell, 12, 723-734.
29. Battaglia,S., Maguire,O. and Campbell,M.J. (2010) Transcription factor co-repressors in cancer biology; roles and targeting. Int. J. Cancer, 126, 2511-2519.
30. Mohn,F. and Schubeler,D. (2009) Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet., 25, 129-136.
31. Mangan,S. and Alon,U. (2003) Structure and function of the feed-forward loop network motif. Proc. Natl Acad. Sci. USA, 100, 11980-11985.
32. Mangan,S., Itzkovitz,S., Zaslaver,A. and Alon,U. (2006) The incoherent feed-forward loop accelerates the response-time of the gal system of Escherichia coli. J. Mol. Biol., 356, 1073-1081.
33. Gatfield,D., Le Martelot,G., Vejnar,C.E., Gerlach,D., Schaad,O., Fleury-Olela,F., Ruskeepaa,A.L., Oresic,M., Esau,C.C., Zdobnov,E.M. et al. (2009) Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev., 23, 1313-1326.
34. Song,G. and Wang,L. (2008) Transcriptional mechanism for the paired miR-433 and miR-127 genes by nuclear receptors SHP and ERRgamma. Nucleic Acids Res., 36, 5727-5735.
35. Ribas,J., Ni,X., Haffner,M., Wentzel,E.A., Salmasi,A.H., Chowdhury,W.H., Kudrolli,T.A., Yegnasubramanian,S., Luo,J., Rodriguez,R. et al. (2009) miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res., 69, 7165-7169.
36. Sun,T., Wang,Q., Balk,S., Brown,M., Lee,G.S. and Kantoff,P. (2009) The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res., 69, 3356-3363.
37. Wang,X., Gocek,E., Liu,C.G. and Studzinski,G.P. (2009) MicroRNAs181 regulate the expression of p27(Kip1) in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D(3). Cell Cycle, 8, 736-741.
38. Ivanovska,I., Ball,A.S., Diaz,R.L., Magnus,J.F., Kibukawa,M., Schelter,J.M., Kobayashi,S.V., Lim,L., Burchard,J., Jackson,A.L. et al. (2008) MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell Biol., 28, 2167-2174.
39. Saramaki,A., Banwell,C.M., Campbell,M.J. and Carlberg,C. (2006) Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res., 34, 543-554. (Pubitemid 43240242)
40. Bello,D., Webber,M.M., Kleinman,H.K., Wartinger,D.D. and Rhim,J.S. (1997) Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis, 18, 1215-1223. (Pubitemid 28132513)
41. Thorne,J. and Campbell,M.J. (2008) The vitamin D receptor in cancer. Proc. Nutr. Soc., 67, 115-127.
42. VerMilyea,M.D., O'Neill,L.P. and Turner,B.M. (2009) Transcription- independent heritability of induced histone modifications in the mouse preimplantation embryo. PLoS ONE, 4, e6086.
43. Velilla,E., Lopez-Bejar,M., Rodriguez-Gonzalez,E., Vidal,F. and Paramio,M.T. (2002) Effect of Hoechst 33342 staining on developmental competence of prepubertal goat oocytes. Zygote, 10, 201-208. (Pubitemid 135714172)
44. Saramaki,A., Diermeier,S., Kellner,R., Laitinen,H., Vaisanen,S. and Carlberg,C. (2009) Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha,25-dihydroxyvitamin D3. J. Biol. Chem., 284, 8073-8082.
45. O'Neill,L.P. and Turner,B.M. (1996) Immunoprecipitation of chromatin. Methods Enzymol., 274, 189-197. (Pubitemid 26353077)
46. O'Neill,L.P., VerMilyea,M.D. and Turner,B.M. (2006) Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations. Nat. Genet., 38, 835-841.
47. Matilainen,M., Malinen,M., Saavalainen,K. and Carlberg,C. (2005) Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Res., 33, 5521-5532. (Pubitemid 41548818)
48. Seuter,S., Vaisanen,S., Radmark,O., Carlberg,C. and Steinhilber,D. (2007) Functional characterization of vitamin D responding regions in the human 5-Lipoxygenase gene. Biochim. Biophys. Acta., 1771, 864-872.
49. Bae,V.L., Jackson-Cook,C.K., Brothman,A.R., Maygarden,S.J. and Ware,J.L. (1994) Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: association with decreased epidermal growth factor receptor (EGFR) expression. Int. J. Cancer, 58, 721-729.
50. El-Deiry,W.S., Tokino,T., Velculescu,V.E., Levy,D.B., Parsons,R., Trent,J.M., Lin,D., Mercer,W.E., Kinzler,K.W. and Vogelstein,B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825. (Pubitemid 23346378)
51. Degenhardt,T., Matilainen,M., Herzig,K.H., Dunlop,T.W. and Carlberg,C. (2006) The insulin-like growth factor-binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors. J. Biol. Chem., 281, 39607-39619.
52. Battaglia,S., Thorne,J., Maguire,O., Hornung,L., Sucheston,L.E., McCabe,C., Bunce,C.M. and Campbell,M.J. (2010) Elevated NCOR1 disrupts PPAR signaling in prostate cancer and forms a targetable epigenetic lesion. Carcinogenesis, 31, 1501-1508.
53. O'Neill,L.P. and Turner,B.M. (2003) Immunoprecipitation of native chromatin: NChIP. Methods, 31, 76-82. (Pubitemid 36945173)
54. Banwell,C.M., MacCartney,D.P., Guy,M., Miles,A.E., Uskokovic,M.R., Mansi,J., Stewart,P.M., O'Neill,L.P., Turner,B.M., Colston,K.W. et al. (2006) Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin. Cancer Res., 12, 2004-2013.
55. Abedin,S.A., Thorne,J.L., Battaglia,S., Maguire,O., Hornung,L.B., Doherty,A.P., Mills,I.G. and Campbell,M.J. (2009) Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells. Carcinogenesis, 30, 449-456.
56. Jensen,S.S., Madsen,M.W., Lukas,J., Binderup,L. and Bartek,J. (2001) Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol. Endocrinol., 15, 1370-1380.
57. Campbell,M.J., Elstner,E., Holden,S., Uskokovic,M. and Koeffler,H.P. (1997) Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J. Mol. Endocrinol., 19, 15-27. (Pubitemid 27345239)
58. Metivier,R., Huet,G., Gallais,R., Finot,L., Petit,F., Tiffoche,C., Merot,Y., LePeron,C., Reid,G., Penot,G. et al. (2008) Dynamics of estrogen receptor-mediated transcriptional activation of responsive genes in vivo: apprehending transcription in four dimensions. Adv. Exp. Med. Biol., 617, 129-138.
59. John,S., Johnson,T.A., Sung,M.H., Biddie,S.C., Trump,S., Koch- Paiz,C.A., Davis,S.R., Walker,R., Meltzer,P.S. and Hager,G.L. (2009) Kinetic complexity of the global response to glucocorticoid receptor action. Endocrinology, 150, 1766-1774.
60. Ellison,T.I., Smith,M.K., Gilliam,A.C. and MacDonald,P.N. (2008) Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J. Invest. Dermatol., 128, 2508-2517.
61. Maruyama,R., Aoki,F., Toyota,M., Sasaki,Y., Akashi,H., Mita,H., Suzuki,H., Akino,K., Ohe-Toyota,M., Maruyama,Y. et al. (2006) Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res., 66, 4574-4583.
62. Lambert,J.R., Kelly,J.A., Shim,M., Huffer,W.E., Nordeen,S.K., Baek,S.J., Eling,T.E. and Lucia,M.S. (2006) Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth. J. Cell Physiol., 208, 566-574. (Pubitemid 44141881)
63. Kommagani,R., Caserta,T.M. and Kadakia,M.P. (2006) Identification of vitamin D receptor as a target of p63. Oncogene, 25, 3745-3751. (Pubitemid 43980495)
64. Stock,J.K., Giadrossi,S., Casanova,M., Brookes,E., Vidal,M., Koseki,H., Brockdorff,N., Fisher,A.G. and Pombo,A. (2007) Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat. Cell Biol., 9, 1428-1435.
65. Brookes,E. and Pombo,A. (2009) Modifications of RNA polymerase II are pivotal in regulating gene expression states. EMBO Rep., 10, 1213-1219.
66. Degenhardt,T., Rybakova,K.N., Tomaszewska,A., Mone,M.J., Westerhoff,H.V., Bruggeman,F.J. and Carlberg,C. (2009) Population-level transcription cycles derive from stochastic timing of single-cell transcription. Cell, 138, 489-501.
67. Jin,F. and Fondell,J.D. (2009) A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression. Nucleic Acids Res., 37, 4826-4838.
68. Okada,M., Takezawa,S., Mezaki,Y., Yamaoka,I., Takada,I., Kitagawa,H. and Kato,S. (2008) Switching of chromatin-remodelling complexes for oestrogen receptor-alpha. EMBO Rep., 9, 563-568. (Pubitemid 351772920)
69. Cohen,E.E., Zhu,H., Lingen,M.W., Martin,L.E., Kuo,W.L., Choi,E.A., Kocherginsky,M., Parker,J.S., Chung,C.H. and Rosner,M.R. (2009) A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Res., 69, 65-74.
70. Brosh,R., Shalgi,R., Liran,A., Landan,G., Korotayev,K., Nguyen,G.H., Enerly,E., Johnsen,H., Buganim,Y., Solomon,H. et al. (2008) p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol. Syst. Biol., 4, 229.
71. Poliseno,L., Salmena,L., Riccardi,L., Fornari,A., Song,M.S., Hobbs,R.M., Sportoletti,P., Varmeh,S., Egia,A., Fedele,G. et al. Identification of the miR-106b∼25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci. Signal, 3, ra29.
72. Resnick,K.E., Alder,H., Hagan,J.P., Richardson,D.L., Croce,C.M. and Cohn,D.E. (2009) The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol., 112, 55-59.
73. Mitchell,P.S., Parkin,R.K., Kroh,E.M., Fritz,B.R., Wyman,S.K., Pogosova-Agadjanyan,E.L., Peterson,A., Noteboom,J., O'Briant,K.C., Allen,A. et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA, 105, 10513-10518.
74. Chen,X., Ba,Y., Ma,L., Cai,X., Yin,Y., Wang,K., Guo,J., Zhang,Y., Chen,J., Guo,X. et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res., 18, 997-1006.
75. Brase,J.C., Johannes,M., Schlomm,T., Falth,M., Haese,A., Steuber,T., Beissbarth,T., Kuner,R. and Sultmann,H. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int. J. Cancer, doi:10.1002/ijc.25376 [April 5; Epub ahead of print].